Sinil Pharmaceutical Co Ltd
KOSDAQ:012790
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sinil Pharmaceutical Co Ltd
KOSDAQ:012790
|
KR |
|
C
|
Canfor Pulp Products Inc
F:8CP
|
CA |
|
Spirit Airlines Inc
OTC:SAVEQ
|
US |
|
VRX Silica Ltd
ASX:VRX
|
AU |
|
I
|
Integer Holdings Corp
NYSE:ITGR
|
US |
|
S
|
Standard Premium Finance Holdings Inc
OTC:SPFX
|
US |
|
1
|
1895 Bancorp of Wisconsin Inc
NASDAQ:BCOW
|
US |
|
Kirloskar Ferrous Industries Ltd
BSE:500245
|
IN |
|
M
|
MinTech Co Ltd
KOSDAQ:452200
|
KR |
|
Bank Syariah Indonesia Tbk PT
IDX:BRIS
|
ID |
|
T
|
Tokai Lease Co Ltd
TSE:9761
|
JP |
|
Barry Callebaut AG
SIX:BARN
|
CH |
Dividends
Dividend Yield
Sinil Pharmaceutical Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Sinil Pharmaceutical Co Ltd
Payout Ratio
Sinil Pharmaceutical Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Sinil Pharmaceutical Co Ltd is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Sinil Pharmaceutical Co Ltd
| Average Annual Return | -19.13% |
| Standard Deviation of Annual Returns | 7.91% |
| Max Drawdown | -68% |
| Market Capitalization | 69.9B KRW |
| Shares Outstanding | 11 990 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Sinil Pharmaceutical Co Ltd's latest stock split occurred on Dec 28, 2022
The company executed a 26-for-25 stock split, meaning that for every 25 shares held, investors received 26 new shares.
Before the split, Sinil Pharmaceutical Co Ltd traded at 8999.9997 per share. Afterward, the share price was about 8690.
The adjusted shares began trading on Dec 28, 2022. This was stock split number 4 in Sinil Pharmaceutical Co Ltd's history, following the previous one in Dec 29, 2021.
